Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00586053 · ClinicalTrials.gov registry record

Unprepped CT Colonography

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
1,255
Enrollment target

NCT00586053: Completed study, sponsored by Mayo Clinic.

NCT00586053 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,255 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00586053 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
1,255 participants
Enrollment target

Study Summary

It is our objective to improve the performance of CTC in the prepared colon, and to validate CTC in the unprepared colon for the detection of colorectal neoplasia. The cost-effectiveness ratio of CTC in the unprepared colon will compare favorably with other colorectal screening test.

Trial Details

FieldValue
Enrollment Target 1,255 participants
Start Date 2000-08
Est. Completion 2009-12
Mayo Clinic

2,844 total trials

What the finished NCT00586053 record still lists

NCT00586053 is an observational study that tracks outcomes without assigning an intervention. Its 1,255 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00586053 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00586053 about?

NCT00586053 is a clinical study titled "Unprepped CT Colonography". It is our objective to improve the performance of CTC in the prepared colon, and to validate CTC in the unprepared colon for the detection of colorectal neoplasia. The cost-effectiveness ratio of CTC in the unprepared colon will compare favorably with other colorectal screening test.

What is the current status of trial NCT00586053?

This trial is currently completed. The enrollment target is 1,255 participants. The study started on 2000-08. Estimated completion is 2009-12.

Who is sponsoring clinical trial NCT00586053?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06712316 · 1,260 participants · Phase 2

    Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • NCT06812273 · 1,260 participants · NA

    Mediators and Moderators of Auditory Training

  • NCT06931340 · 1,260 participants · Phase 3

    Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • NCT02743858 · 1,250 participants

    Lymphedema Surveillance Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00586053, the US trial registry maintained by the National Library of Medicine. NCT00586053 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.